United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Hot Topics: Life Sciences - October 2025

This update focuses on: the UK's fall in global rankings for pharmaceutical investment; the importance of managing IP risks carefully when investing in US life sciences...

United Kingdom Healthcare

AG

Addleshaw Goddard

How MHRA's International Reliance Is Shaping UK Medicine Regulation

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is entering a new era—one defined by speed, trust, and global collaboration.

United Kingdom Healthcare

BJ

Browne Jacobson

Technology-Enabled Care In The UK: Legal And Technical Developments To Watch

Technology-enabled care ("TEC") – which includes remote monitoring, telecare, smart-home sensors and care-focused apps – has moved from niche pilot projects into mainstream health and social care across the UK

United Kingdom Healthcare

BJ

Browne Jacobson

The Dog That Barks: The UK's CMA Is Proposing Major Reforms To Veterinary Businesses

Following a two year investigation, the UK's Competition and Markets Authority ("CMA") has issued its provisional findings in which it proposes to impose significant obligations on veterinary business.

United Kingdom Healthcare

AP

Arnold & Porter

Arbitrating Innovation: Resolving IP Disputes In The Life Sciences Sector

United Kingdom Healthcare

BJ

Browne Jacobson

The Importance Of AI In The Development Life Sciences

United Kingdom Healthcare

BJ

Browne Jacobson

MHRA And NICE Launch Aligned Approvals Pathway

United Kingdom Healthcare

AP

Arnold & Porter

Biopharma M&A Activity – Strategics Continue To Lead The Way

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Venture Investment In Life Sciences – Activity Update & Outlook (US & Europe)

Worldwide Healthcare

KL

Herbert Smith Freehills Kramer LLP

EU Data Act: Is Your Business Ready?

European Union Privacy

AG

Addleshaw Goddard

AI In Medical Devices: Patent Eligibility

United Kingdom IP

MC

Marks & Clerk

Article 22 Trends In Pharma M&A: Call-In Powers And Timing

United Kingdom Healthcare

AP

Arnold & Porter

Interview With Citrine Informatics: AI, Data, And The Future Of Materials Science

United Kingdom Technology

KL

Keltie LLP

A Milestone For Precision Breeding But Will The UK-EU Reset Pause Progress?

European Union Healthcare

M

Murgitroyd

Webinar Recording: Employment Law Lab - September Edition 2025 (Video)

United Kingdom Employment

BP

Burness Paull

Goodwin Insight: French Governance Of The European Artificial Intelligence Regulation

United Kingdom Technology

GP

Goodwin Procter LLP

Shaping The Future Of Build To Rent: Quintain Living At Wembley Park (Podcast)

United Kingdom Real Estate

GW

Gowling WLG

Navigating The EU Data Act: Key Obligations And A Spotlight On Switching Rights

United Kingdom Commercial

GP

Goodwin Procter LLP

Culture & Compliance Chronicles: Boardroom Agility—Strategies For Modern Boards Managing Crises, Compliance & Collective Responsibility (Podcast)

United Kingdom Commercial

RG

Ropes & Gray LLP

Biopharma M&A Activity – As We Enter The Latter Months Of 2025, Strategics Continue To Lead The Way

As we entered 2025, we were hopeful for a more upbeat year for pharma M&A activity but, with headwinds still swirling, a dramatic change of pace seemed unlikely.

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Supporting Growth - What Does The UK's Industrial Strategy Mean For Infrastructure?

The return of the UK Industrial Strategy (UKIS) the last edition of which was published by Theresa May's Government in 2017, represents a "statement of intent" by the UK Government of the areas where it will seek...

United Kingdom Energy

GW

Gowling WLG

Life After Separation: What The Future Holds For Pharma Companies And Their Divested Consumer Healthcare Divisions

In recent years, many of the world's biggest pharmaceutical companies have carved out and spun off their consumer health divisions in an effort to refocus on core strategic areas and free up cash for investment

United Kingdom Healthcare

AO

A&O Shearman

Immigration And The UK's Industrial Vision

In today's global economy, competition to attract the most desirable talent is fierce with many countries seeking to improve their attractiveness.

United Kingdom Immigration

LS

Lewis Silkin

AI In The Healthcare Sphere: Public And Private Considerations

United Kingdom Technology

BJ

Browne Jacobson

European Biosimilar Updates – Alvotech/Advanz's MYNZEPLI Approval And Bio-Thera/STADA Tocilizumab Alliance

European Union Healthcare

GP

Goodwin Procter LLP

Hot Topics: Life Sciences

United Kingdom Healthcare

AG

Addleshaw Goddard

Neurotech Patents In Europe: Methods, Medical Devices, And The EPC Exclusion

United Kingdom IP

MC

Marks & Clerk

The Thursday Investment Club: The Case For Later Living

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Tackling Tech Debt, Unlocking Value In Healthcare Portfolio Companies

United Kingdom Healthcare

A

AlixPartners

Court Of Appeal Deals With Price-less Contract

United Kingdom Litigation

LS

Lewis Silkin

Leading The Way In Life Sciences IP: Q&A With Laura Kehoe

United Kingdom IP

KL

Keltie LLP

Early Access Service To Launch For Innovative Medical Devices

United Kingdom Healthcare

BJ

Browne Jacobson

UK Court Of Appeal Upholds Moderna MRNA Patent Against Pfizer/BioNTech

United Kingdom IP

GP

Goodwin Procter LLP

Court Of Appeal Deals With Price-less Contract

Recently, in the case of KSY Juice Blends UK Ltd v Citrosuco GmbH [2025] EWCA Civ 760, the Court of Appeal considered contractual certainty and implied pricing terms for water-extracted soluble orange solids ("wesos").

United Kingdom Litigation

LS

Lewis Silkin

Leading The Way In Life Sciences IP: Q&A With Laura Kehoe

Keltie is rated as ‘Outstanding' in the 2025 WIPR UK Patents Rankings. This ranking recognises the top firms in UK patent law for their expertise, reputation and client service.

United Kingdom IP

KL

Keltie LLP

Early Access Service To Launch For Innovative Medical Devices

A key platform of the government's Life Sciences Sector Plan and the 10-Year Health Plan is for the UK to be a global leader in life sciences.

United Kingdom Healthcare

BJ

Browne Jacobson

UK Court Of Appeal Upholds Moderna MRNA Patent Against Pfizer/BioNTech

On August 1, 2025, a UK Court of Appeal upheld the validity of Moderna's European Patent No. 3,590,949 ("EP'949") in a dispute with Pfizer and BioNTech.

United Kingdom IP

GP

Goodwin Procter LLP

Launch Of The Biotech And Biomanufacturing Hub

United Kingdom IP

B

Boult Wade Tennant

Watch What The Federal Government Does, Not What It Says, About Artificial Intelligence

Since the Trump Administration's start, its speak has been all about "removing the barriers to American leadership in artificial intelligence."

United Kingdom Technology

IG

IR Global

Product Regulation And Metrology Bill Receives Royal Assent

The Product Regulation and Metrology Act 2025 reforms the UK's post-Brexit product safety, metrology, and consumer protection frameworks.

United Kingdom Healthcare

JD

Jones Day

Hot Topics: Life Sciences

This update focuses on: the European Commission's new strategy for life sciences; the latest on tariffs on pharmaceutical imports; Microsoft introduces it's new AI diagnostic tool...

United Kingdom Healthcare

AG

Addleshaw Goddard

Virtual And Digital Health Digest – July 2025

This digest covers key virtual and digital health regulatory and public policy developments during June and early July 2025 from the United Kingdom and European Union.

United Kingdom Healthcare

AP

Arnold & Porter

Supporting Growth: The UK's Plan To Unlock The Potential Of Life Sciences

United Kingdom Healthcare

GW

Gowling WLG

The UK Government Has Plans: What Does This Mean For The Life Sciences Sector?

United Kingdom Healthcare

AP

Arnold & Porter

Life Science Sector Plans Issued

United Kingdom Healthcare

LS

Lewis Silkin

A New European Strategy To Foster Life Sciences Innovation And Market Access

European Union Healthcare

AO

A&O Shearman

Tackling The Source Of Phantom Limb Pain With Nerve Stimulation

United Kingdom IP

MC

Marks & Clerk

The Case For Core Focus Among Mid-market Medical Device Companies

United Kingdom Healthcare

A

AlixPartners

Neurotech Patents In Europe: Part 2 - Novelty, Inventive Step, And Device-Specific Pitfalls

United Kingdom IP

MC

Marks & Clerk

Creative Deal Structures Help Life Sciences Innovators Ride Out The Macro Storm

United Kingdom Commercial

AO

A&O Shearman

UK Government Issues Tech And Digital Sector Plan

United Kingdom Technology

LS

Lewis Silkin

The Cali Fund And DSI: What Life Sciences And Biotech Companies Need To Know Now

Worldwide Healthcare

PC

Potter Clarkson

The Pioneers: Financial Times Interview With Michelle Mitchell

United Kingdom Healthcare

WL

Withers LLP

Supporting Growth – What Does The UK's Industrial Strategy Mean For Life Sciences?

United Kingdom Healthcare

GW

Gowling WLG

UK Government Issues New Industrial Strategy

United Kingdom Strategy

LS

Lewis Silkin

EU Medical Device Software: New Guidance On Placing Software Medical Devices On The EU Market

European Union Healthcare

AP

Arnold & Porter

Personalised Medicine And MedTech

United Kingdom Healthcare

LS

Lewis Silkin

See more

Latest Videos

See more

Latest Trends With EMA And MHRA Inspections In The EU And UK

AP

Arnold & Porter

Legally Vocal: Patrick Duxbury On His COVID-19 Vaccine Work And 20-Year Career In Life Sciences (Video)

GW

Gowling WLG

Webinar: Supplementary Protection Certificates - Part Two (Video)

D

Dehns

Claim One – #01 EPO Oral Proceedings (Video)

H

HLK

Real World Evidence (Video Content)

D

Deloitte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More